Labeled for this condition
Medicines for copd
23 medicines have an FDA label indicated for COPD; 8 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for copd?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Fluticasone and salmeterol | Advair, Airduo, Wixela | 8 labelers | $1.07 per unit 100-50 | No | A presentation being discontinued | 3 |
| Ipratropium | Atrovent | 23 labelers | $0.111 per mL 0.02% solution | No | No current entry | 1 |
| Roflumilast | Zoryve, Daliresp | 15 labelers | $0.311 per tablet 500 mcg tablet | No | No current entry | 0 |
| Albuterol and ipratropium | Combivent | 14 labelers | $0.0787 per mL 0.5-3(2.5) mg/3 mL | No | No current entry | 5 |
| Budesonide and formoterol | Symbicort, Breyna | 2 labelers | $17.26 per gram 160-4.5 | No | No current entry | 1 |
| Arformoterol | none listed | 15 labelers | $0.633 per mL 15 mcg/2 mL solution | No | No current entry | 2 |
| Formoterol | Perforomist | 11 labelers | $1.30 per mL 20 mcg/2 mL neb vial | No | No current entry | 0 |
| Tiotropium | Spiriva | 1 labeler | $11.81 per capsule 18 mcg capsule-inhaler | No | No current entry | 5 |
| Fluticasone and vilanterol | Breo | none listed | $3.90 per unit 100-25 | No | No current entry | 0 |
| Dupilumab | Dupixent | none listed | $1,773.74 per mL 200 mg/1.14 mL syring | No | No current entry | 0 |
| Mepolizumab | Nucala | none listed | n/a | No | No current entry | 1 |
| Budesonide and formoterol and glycopyrrolate | Breztri | none listed | $61.41 per gram 160-9-4.8 mcg | No | No current entry | 0 |
| Fluticasone and umeclidinium and vilanterol | Trelegy | none listed | $11.12 per unit 100-62.5-25 | No | No current entry | 2 |
| Umeclidinium | Incruse | none listed | $7.35 per inhaler 62.5 mcg inhaler | No | No current entry | 0 |
| Umeclidinium and vilanterol | Anoro | none listed | $4.95 per inhaler 62.5-25 mcg inhaler | No | No current entry | 1 |
| Aclidinium | Tudorza | none listed | $344.55 per unit 400 mcg inhal | No | No current entry | 0 |
| Aclidinium and formoterol | Duaklir | none listed | n/a | No | No current entry | 0 |
| Ensifentrine | Ohtuvayre | none listed | n/a | No | No current entry | 0 |
| Formoterol and glycopyrrolate | Bevespi | none listed | $40.86 per gram Bevespi aerosphere inhaler | No | No current entry | 1 |
| Olodaterol | Striverdi | none listed | $65.94 per gram Striverdi respimat inhal spray | No | No current entry | 0 |
| Olodaterol and tiotropium | Stiolto | none listed | $115.80 per gram 60) | No | No current entry | 0 |
| Revefenacin | Yupelri | none listed | $17.43 per mL 175 mcg/3 mL solution | No | No current entry | 0 |
| Salmeterol | Serevent | none listed | $6.74 per unit 50 mcg | Yes | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price